A Review for Usefulness of Atypical Antipsychotics and Cholinesterase Inhibitors in Delirium

Abstract

Although the information from Gover et al (2011) is comprehensive it does not include vital information for management of delirium from key studies in this area of research. This paper has summarised information as lists and tables without systematic critical appraisal. Therefore, in the absence of a robust methodology for literature search and critical appraisal of past and current literature, it has limited implications to help future management or research in the field of delirium.

Key words

acetylcholinesterase - delirium - dopamine antagonist - antipsychotic drugs - quetiapine

• References

• 1 Grover S, Matoo S, Gupta N. Usefulness of atypical antipsychotics and choline esterase inhibitors in delirium: A review. Pharmacopsychiatry epub ahead of print
• 2 Bourne R, Tahir TA, Baothwick M, Sampson E. Treatment of delirium: past, present and future. J Psychosom Res 2008; 66: 22-55
• 3 Tahir TA, Morgan E, Eeles E. NICE Guideline: Evidence for pharmacological treatment of delirium. J Psychosom Res 2011; 70: 197-198
• 4 Tahir TA, Eeles E, Karapareddy V. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 2010; 68: 485-490
• 5 Van Eijk MM, Roes KC, Honing ML et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind placebo-controlled randomised trial. Lancet 2010; 376: 1829-1837
• 6 Overshott R, Vernon M, Morris J et al. Rivastigmine in the treatment of delirium in older people: a pilot study. Int Psychogeriatr 2010; 22: 812-818
• 7 Kim SW, Yoo JA, Lee SY et al. Rispiridone versus olanzapine for the treatment of delirium. Hum Psychopharmacol 2010; 25: 298-302